Fig. 4. Bivariate distribution of 
pre- and posttreatment HSV-2 IgG antibody titer levels and mean postrelaxation stress levels.
Fig. 4. Bivariate distribution of pre- and posttreatment HSV-2 IgG antibody titer levels and mean postrelaxation stress levels.